Dr. David C. Delgado

Hematology | Oncology
Riley Hospital For Children At Indiana University Health
705 Riley Hospital Dr, 
Indianapolis, IN 
20 Years of Experience
Riley Hospital For Children At Indiana University Health
705 Riley Hospital Dr, 
Indianapolis, IN 

Overview

David Delgado is a Hematologist and an Oncologist practicing medicine in Indianapolis, Indiana. He has been practicing medicine for over 20 years.

His clinical expertise encompasses Acute Myeloid Leukemia (AML), Hemoglobinopathy, Leukemia, Graft Versus Host Disease (GvHD), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 3 clinical trials.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in IN

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Riley Hospital for Children at Indiana University Health
705 Riley Hospital Dr, Indianapolis, IN 46202

Additional Areas of Focus

Dr. Delgado has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Enrollment Status: Unknown
Publish Date: February 08, 2023
Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents
Mechanisms of Active Music Engagement to Improve Health Outcomes of Children With Cancer and Parents
Enrollment Status: Completed
Publish Date: November 11, 2021
Intervention Type: Behavioral
Study Phase: Not Applicable
A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease (aGVHD) Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant (Allo HSCT) Patients
A Multicenter Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease (aGVHD) Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant (Allo HSCT) Patients
Enrollment Status: Completed
Publish Date: March 22, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 2 Less Clinical Trials

15 Total Publications

Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 24, 2020
Similar Doctors
Expertise in
14
conditions
Dr. Brian D. Weiss
Hematology | Oncology
Expertise in
14
conditions
Dr. Brian D. Weiss
Hematology | Oncology
Referral may be required

Riley Hospital For Children At Indiana University Health

705 Riley Hospital Dr, 
Indianapolis, IN 
 (0.1 miles away)
317-944-2143
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Brian Weiss is a Hematologist and an Oncologist practicing medicine in Indianapolis, Indiana. Dr. Weiss is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Neurofibromatosis, Lithotripsy, and Bone Marrow Transplant. Dr. Weiss is currently accepting new patients.

Expertise in
6
conditions
Dr. Amy D. Shapiro
Hematology | Oncology
Expertise in
6
conditions
Dr. Amy D. Shapiro
Hematology | Oncology
Referral may be required

Indiana Hemophilia And Thrombosis Center Inc

8326 Naab Rd, 
Indianapolis, IN 
 (9.0 miles away)
317-871-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Amy Shapiro is a Hematologist and an Oncologist practicing medicine in Indianapolis, Indiana. Dr. Shapiro is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Blood Clots, Hemophilia A, Hemophilia B, and Ligneous Conjunctivitis. Dr. Shapiro is currently accepting new patients.

Expertise in
29
conditions
Dr. Daniel A. Rushing
Hematology | Oncology
Expertise in
29
conditions
Dr. Daniel A. Rushing
Hematology | Oncology
Referral may be required

Univ. Radiation Oncology Associates Inc.

535 Barnhill Dr, 
Indianapolis, IN 
 (0.2 miles away)
317-948-8310
Languages Spoken:
English
See accepted insurances

Daniel Rushing is a Hematologist and an Oncologist practicing medicine in Indianapolis, Indiana. Dr. Rushing is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Fibrosarcoma, and Bone Tumor.

Frequently Asked Questions about Dr. David C. Delgado

How do I make an appointment with Dr. David C. Delgado?

You can book an appointment with Dr. David C. Delgado by calling their office at 317-944-2143. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. David C. Delgado a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. David C. Delgado is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. David C. Delgado specialize in?

While Dr. David C. Delgado is a Hematology, they have specific expertise in Acute Myeloid Leukemia (AML), Hemoglobinopathy, and Bone Marrow Transplant. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. David C. Delgado participate in research or clinical trials?

Yes. Dr. David C. Delgado has published 15 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Dr. David C. Delgado's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Delgado's expertise for a condition
ConditionClose
        View All 11 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile